Intracoronary Stenting Strategies

  • Peter Lanzer


Intracoronary stenting has largely improved the safety and acute efficacy of coronary interventions. However, the long-term results did not yet quite fulfill the expectation. It can be hypothesized that acute benefits of stenting may be partly set off by current gaps in knowledge of interactions between stents and coronary walls and suboptimal stent implantation techniques resulting in long-term complications. In this chapter, current concept of intracoronary stent implantations, related complications, and resulting limitations are reviewed.


Optical Coherence Tomography Stent Thrombosis Major Adverse Cardiac Event Bare Metal Stent Percutaneous Coronary Intervention 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Wijns W, Kolh P, Danchin M, di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Uvas MS (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555PubMedCrossRefGoogle Scholar
  2. 2.
    Garg S, Serruys PW (2010) Coronary stents; current status. J Am Coll Cardiol 56:S1–S42PubMedCrossRefGoogle Scholar
  3. 3.
    Garg S, Serruys PW (2010) Coronary stents; looking forward. J Am Coll Cardiol 56:S43–S78PubMedCrossRefGoogle Scholar
  4. 4.
    Lanzer P, Prechelt L (2008) Spelling out risk reduction strategies for intracoronary stenting. EuroIntervention 3:622–626PubMedCrossRefGoogle Scholar
  5. 5.
    Gould KL (1999) Coronary artery stenosis and reversing atherosclerosis. Arnold, LondonGoogle Scholar
  6. 6.
    Mintz GS, Weissman NJ (2006) Intravascular ultrasound in the drug-eluting stent era. J Am Coll Cardiol 48:421–429PubMedCrossRefGoogle Scholar
  7. 7.
    Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van’t Veer M, Klauss V, Manoharan G, Engström T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213–224PubMedCrossRefGoogle Scholar
  8. 8.
    Hein R, Escaned J, Klauss V (2010) Assessment of stenosis severity with intracoronary pressure and thermodilution measurements. In: Escaned J, Serruys PW (eds) Coronary stenosis imaging, structure and physiology. PCR Publishing, Toulouse, pp 355–376Google Scholar
  9. 9.
    Kiousis DE, Gasser TE, Holzapfel GA (2007) A numerical model to study the interaction of vascular stents with human atherosclerotic lesions. Ann Biomech Eng 35:1857–1869CrossRefGoogle Scholar
  10. 10.
    Lozano I, Lopez-Palop R, Pinar E, Perez-Lorente F, Pico F, Valdes M (2006) Comparison between theoretical and actual intracoronary stent dimensions in complex lesions. Rev Esp Cardiol 59:624–627PubMedCrossRefGoogle Scholar
  11. 11.
    Mintz GS, Popma JJ, Pichard AD, Kent KM, Sattler LF, ChuangYC DCJ, Leon MB (1995) Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation 91:1959–1965PubMedCrossRefGoogle Scholar
  12. 12.
    Fischer JJ, Samady H, McPherson JA, Sarembock IJ, Powers ER, Gimple LW, Ragosta M (2002) Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native coronary narrowings of moderate severity. Am J Cardiol 90:210–215PubMedCrossRefGoogle Scholar
  13. 13.
    Ambrose JA, Lardizabal JA (2010) Angiographic evaluation of coronary stenosis: a historical perspective. In: Escaned J, Serruys PW (eds) Coronary stenosis imaging, structure and physiology. PCR Publishing, Toulouse, pp 161–168Google Scholar
  14. 14.
    Roubin GS, Douglas JS Jr, King SB III, Lin S, Hutchinson N, Thomas RG, Grüntzig AR (1998) Influence of balloon size on initial success, acute complications, and restenosis after percutaneous coronary angioplasty. Circulation 78:557–565CrossRefGoogle Scholar
  15. 15.
    Duprat G, David PR, Lesperance J, Val PG, Fines P, Robert P, Bourassa MG (1984) An optimal size of balloon catheter is critical to angiographic success early after PTCA. Circulation 70(Suppl II):11–295Google Scholar
  16. 16.
    Mintz GS, Nissen SE, for the writing committee members et al (2001) American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies. J Am Coll Cardiol 37:1478–1492PubMedCrossRefGoogle Scholar
  17. 17.
    Hermiller JB, Tanaglia AN, Kisslo KB, Phillips HR, Bashore TM, Stack RS, Davidson CJ (1993) In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 71:665–668PubMedCrossRefGoogle Scholar
  18. 18.
    Stone GW, Hodgson JM, St Goar FG, Frey A, Mudra A, Sheehan H, Linnemeier TJ (1997) Improved procedural results of coronary angioplasty with intravascular ultrasound–guided balloon sizing; The CLOUT Pilot Trial. Circulation 95:2044–2052PubMedCrossRefGoogle Scholar
  19. 19.
    Romagnoli E, Sangiorgi GM, Cosgrave J, Guillet E, Colombo A (2008) Drug-eluting stenting; the case for post-dilatation. JACC Cardiovasc Interv 1:22–31PubMedCrossRefGoogle Scholar
  20. 20.
    de Jaegere P, Mudra H, Figulla H, Almagor Y, Doucet S, Penn I, Colombo A, Hamm C, Bartorelli A, Rothman M, Nobuyoshi M, Yamaguchi T, Voudris V, DiMario C, Makovski S, Hausmann D, Rowe S, Rabinovich S, Sunamura M, Van Es GA (1998) Intravascular ultrasound-guided optimized stent deployment: immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J 19:1214–1223PubMedCrossRefGoogle Scholar
  21. 21.
    Fischman DL, Leon MB, Baim DS, for the Stent Restenosis Study Investigators et al (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496–501PubMedCrossRefGoogle Scholar
  22. 22.
    Serruys PW, de Jaegere P, Kiemeneij F, for the BENETEST Study Group et al (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489–495PubMedCrossRefGoogle Scholar
  23. 23.
    Rogers C, Tseng DY, Squire JC, Edelman ER (1999) Balloon–artery interactions during stent placement; a finite element analysis approach to pressure, compliance, and stent design as contributors to vascular injury. Circ Res 84:378–383PubMedCrossRefGoogle Scholar
  24. 24.
    Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camprud AR, Vliestra RE, Holmes DR (1992) Restenosis and the proportional neointimal response to coronary artery injury: results in porcine model. J Am Coll Cardiol 19:267–274PubMedCrossRefGoogle Scholar
  25. 25.
    Farb A, Weber DK, Kolodgie FR, Burek AP, Virmani R (2002) Morphological predictors of restenosis after coronary stenting in humans. Circulation 105:2974–2980PubMedCrossRefGoogle Scholar
  26. 26.
    Costa MA, Anigiolillo DJ, Tannenbaum M, Driesmann M, Chu A, Patterson J, Kuehl W, Battaglia J, Dabbons S, Shamoon F, Flieshman B, Niederman A, Bass TA (2008) Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). Am J Cardiol 101:1704–1711PubMedCrossRefGoogle Scholar
  27. 27.
    Morino Y, Tamiya S, Masuda N, Kawamura Y, Nagaoka M, Matsukage T, Ogata N, Nakazawa G, Tanabe T, Ikari Y (2010) Intravascular ultrasound criteria for determination of optimal longitudinal positioning of sirolimus-eluting stents. Circ J 74:1609–1616PubMedCrossRefGoogle Scholar
  28. 28.
    Mintz G, Garcia-Garcia H, Nicholls S, Weissman N, Bruining N, Crowe T, Tardif J-C, Serruys PW (2011) Clinical expert consensus on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. EuroIntervention 6:195–202CrossRefGoogle Scholar
  29. 29.
    Dishmon DA, Elhaddi A, Packard K, Gupta V, Fischell TA (2011) High incidence of inaccurate stent placement in the treatment of coronary aorto-ostial disease. J Invasive Cardiol 23:322–326PubMedGoogle Scholar
  30. 30.
    Colombo A, Hall PP, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JL (1995) Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91:1676–1688PubMedCrossRefGoogle Scholar
  31. 31.
    Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg SL, Maiello L, Finci L, Tobis JM (1994) Intracoronary ultrasound observations during stent implantation. Circulation 89:2026–2034PubMedCrossRefGoogle Scholar
  32. 32.
    Nakamura S, Hall P, Gaglione A, Tiecco F, Die Maggio M, Maiello L, Martini G, Colombo A (1997) High pressure assisted coronary stent implantation accomplished without ultrasound guidance and subsequent anticoagulation. J Am Coll Cardiol 29:21–27PubMedCrossRefGoogle Scholar
  33. 33.
    Dirschinger J, Kastrati A, Neumann F-J, Boekstegers P, Elezi S, Mehilli J, Schühlen H, Pache J, Alt E, Blasini R, Steinbeck G, Schömig A (1999) Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome. Circulation 100:918–923PubMedCrossRefGoogle Scholar
  34. 34.
    Basalus MW, Ankone MJ, van Houwelingen GK, de Man FH, von Birgelen C (2009) Coating irregularities as assessed by scanning electron microscopy. EuroIntervention 5:157–165PubMedCrossRefGoogle Scholar
  35. 35.
    Capelli C, Nordmeyer J, Schievano S, Lurz P, Khambadkone S, Lattanzio S, Taylor AM, Petrini L, Migliavacca F, Bonhoeffer P (2010) How do angioplasty balloons work; a computational study on balloon expansion forces. EuroIntervention 6:638–642PubMedCrossRefGoogle Scholar
  36. 36.
    Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Vimani R (2005) Differential responses of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112:270–278PubMedCrossRefGoogle Scholar
  37. 37.
    Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB (1999) Angiographic pattern of in-stent restenosis; classification and implications for long-term outcome. Circulation 100:1872–1878PubMedCrossRefGoogle Scholar
  38. 38.
    Räber L, Jüni P, Löffel L, Wandel S, Cook S, Wenaweser P, Togni M, Vogel R, Seiler C, Eberli F, Lüscher T, Meier B, Windecker S (2010) Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol 55:1178–1188PubMedCrossRefGoogle Scholar
  39. 39.
    Park D-W, Kim Y-H, Song H-G, Ahn J-M, Kim W-J, Lee J-W, Kang S-J, Lee S-W, Lee CW, Park S-W, Yun S-C, Seung K-B, Yang T-H, Lee S-G, Lee J-H, Seong I-W, Cheong S-S, Lee B-K, Lee N-H, Lee S-W, Lee S-W, Lee K, Kim H-S, Jeon D-S, Kim M-K, Nah D-Y, Tahk S-J, Park S-J (2011) Comparison of everolimus-eluting and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES III trial. JACC Cardiovasc Interv 4(10):1096–1103PubMedCrossRefGoogle Scholar
  40. 40.
    Ahn J-M, Park D-W, Kim Y-H, Song HG, Kim W-J, Lee J-Y, Kang S-J, Lee S-W, Lee CW, Park S-W, Yun S-C, Han S-B, Lee SY, Lee B-K, Cho J-H, Yang T-H, Lee N-H, Yang J-Y, Park J-S, Shin W-Y, Kim MH, Bae JH, Kim M-K, Yoon J, Park S-J. Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV Trial. JACC Cardiovasc Interv. 2011;4:1096–1103Google Scholar
  41. 41.
    Sharp ASP, Latib A, Ielasi A, Larosa C, Godino C, Saolini M, Magni V, Gerber RT, Montorfano M, Carlino M, Michev I, Chieffo A, Colombo A (2009) Long-term follow-up on a large cohort of “full-metal jacket” percutaneous coronary intervention procedures. Circ Cardiovasc Interv 2:416–422PubMedCrossRefGoogle Scholar
  42. 42.
    Schmidt W, Lanzer P, Behrens P, Topoleski T, Schmitz K-P (2009) On mechanical performance of drug-eluting stents; comparison of seven stent systems. Catheter Cardiovasc Interv 73:350–360PubMedCrossRefGoogle Scholar
  43. 43.
    Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, Pedrazzi G, Hornig B, Bertel O, Bonetti P, De Serve S, Brunner-La Rocca H-P, Ricard I, Pfisterer M (2010) Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med 363:2310–2319PubMedCrossRefGoogle Scholar
  44. 44.
    Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabate M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Juni P (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370:937–948PubMedCrossRefGoogle Scholar
  45. 45.
    Daemen J, Simoons ML, Wijns W, Bagust A, Bos G, Bowen JM, Braunwald E, Camenzind E, Chevalier B, Di Mario C, Fajadet J, Gitt A, Guagliumi G, Hillege HL, James S, Juni P, Kastrati A, Kloth S, Kristensen SD, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys PW, Silber S, Steg PG, Tariah I, Wallentin L, Windecker SW, Aimonetti A, Allocco D, Baczynska A, Bagust A, Berenger M, Bos G, Boam A, Bowen JM, Braunwald E, Calle JP, Camenzind E, Campo G, Carlier S, Chevalier B, Daemen J, de Schepper J, Di Bisceglie G, Di Mario C, Dobbels H, Fajadet J, Farb A, Ghislain JC, Gitt A, Guagliumi G, Hellbardt S, Hillege HL, Ten Hoedt R, Isaia C, James S, de Jong P, Juni P, Kastrati A, Klasen E, Kloth S, Kristensen SD, Krucoff M, Legrand V, Lekehal M, Lenarz L, Ni MF, Nagai H, Patteet A, Paunovic D, Pfisterer M, Potgieter A, Purdy I, Raveau-Landon C, Rothman M, Serruys PW, Silber S, Simoons ML, Steg PG, Tariah I, Ternstrom S, Van Wuytswinkel J, Waliszewski M, Wallentin L, Wijns W, Windecker SW (2009) ESC forum on drug eluting stents European Heart House, Nice, 27–28 September 2007. Eur Heart J 30:152–161PubMedGoogle Scholar
  46. 46.
    Ielasi A, Latib A, Colombo A (2011) Current and future drug-eluting coronary stent technology. Expert Rev Cardiovasc Ther 9:485–503PubMedCrossRefGoogle Scholar
  47. 47.
    Lanzer P, Gijsen FJ, Topoleski LD, Holzapfel GA (2010) Call for standards in technical documentation of intracoronary stents. Herz 35:27–33PubMedCrossRefGoogle Scholar
  48. 48.
    Lanzer P (2006) Coronary arteries. In: Lanzer P (ed) Mastering endovascular techniques; a guide to excellence. Lippincott Williams & Wilkins, Philadelphia, pp 201–205Google Scholar
  49. 49.
    Girasis C, Serruys PW (2010) Contemporary angiographic analysis of coronary stents. In: Escaned J, Serruys PW (eds) Coronary stenosis imaging, structure and physiology. PCR Publishing, Toulouse, pp 169–181Google Scholar
  50. 50.
    Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (2007) Universal definition of myocardial infarction. Circulation 116:2634–2653PubMedCrossRefGoogle Scholar
  51. 51.
    Prasad A, Herrmann J (2011) Myocardial infarction due to percutaneous coronary intervention. N Engl J Med 364:453–464PubMedCrossRefGoogle Scholar
  52. 52.
    Herrmann J (2005) Peri-procedural myocardial injury: 2005 update. Eur Heart J 26:2493–2519PubMedCrossRefGoogle Scholar
  53. 53.
    Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es G-A, Steg PG, Morel M-A, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, on behalf of the Academic Research Consortium (2007) Clinical end points in coronary stent trials. Circulation 115:2344–2351PubMedCrossRefGoogle Scholar
  54. 54.
    Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials; a consensus report from the Bleeding Academic Research Consortium. Circulation 123:2736–2747PubMedCrossRefGoogle Scholar
  55. 55.
    Ryan TJ, Faxon DP, Gunnar RM et al (1988) Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. J Am Coll Cardiol 12:529–545CrossRefGoogle Scholar
  56. 56.
    Sianos G, Morel M-A, Kappetein AP, Morice M-C, Colombo A, Dawkins K, van den Brand M, van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219–227PubMedGoogle Scholar
  57. 57.
    Leaman DM, Brower RW, Messter GT, Serruys P, van den Brand M (1981) Coronary artery atherosclerosis: severity of disease, severity of angina pectoris and compromised left ventricular function. Circulation 63:285–299PubMedCrossRefGoogle Scholar
  58. 58.
    Garg S, Sarno G, Garcia-Garcia HM, Girasis C, Wykrzykowska J, Dawkins KD, Serruys PW (2010) A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score. Circ Cardiovasc Interv 3:317–326PubMedCrossRefGoogle Scholar
  59. 59.
    Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, Shaw RE, Roe MT, Ho KKL, Klein LW, Krone RJ, Weintraub WS, Brindis RG, Rumsfeld JS, Spertus JA, on behalf of NCDR Registry participants (2010) Contemporary mortality risk prediction for percutaneous coronary intervention. J Am Coll Cardiol 55:1923–1932PubMedCrossRefGoogle Scholar
  60. 60.
    Locca D, Bucciarelli Ducci C, Ferrante G, La Manna A, Keenan NG, Grasso A, Barlis P, Del Furia F, Prassad SK, Kaski JC, Pennell DJ, Di Mario C (2010) New universal definition of myocardial infarction; applicable after complex percutaneous coronary interventions? JACC Cardiovasc Interv 3:950–958PubMedCrossRefGoogle Scholar
  61. 61.
    Lansky AJ, Stone GW (2010) Periprocedural myocardial infarction; prevalence, prognosis and prevention. Circ Cardiovasc Interv 3:602–610PubMedCrossRefGoogle Scholar
  62. 62.
    Hoffmann SJ, Holmes DR Jr, Rabinstein AA, Rihal CS, Gersh BJ, Lennon RJ, Bashir R, Gulati R (2011) Trends, predictors, and outcome of cerebrovascular events related to percutaneous coronary intervention; a 16-year single-center experience. JACC Cardiovasc Interv 4:415–422CrossRefGoogle Scholar
  63. 63.
    Applegate RJ, Sacrinty MT, Kutchrer MA, Kahl FR, Gandhi SK, Santos RM, Little WC (2008) Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention vie femoral artery. JACC Cardiovasc Interv 1:317–326PubMedCrossRefGoogle Scholar
  64. 64.
    Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixetta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, Stone GW (2011) Impact of bleeding on mortality after percutaneous coronary intervention; results from a patient-level pooled analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) and HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trials. JACC Cardiovasc Interv 6:654–664CrossRefGoogle Scholar
  65. 65.
    Costa JR, Sousa A, Moreira AC, Costa RA, Cano M, Maldonado G, Campos C, Carballo M, Pavanello R, Sousa JE (2010) Incidence and predictors of very late (≥4 years) major adverse events in the DESIRE (Drug-Eluting Stents in the Real world) – late registry. JACC Cardiovasc Interv 3:12–18PubMedCrossRefGoogle Scholar
  66. 66.
    Marx SO, Totary-Jain H, Marks AR (2011) Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 4:104–111PubMedCrossRefGoogle Scholar
  67. 67.
    Farb A, Weber DK, Kolodgie FD, Virmani R (2002) Morphological predictors of restenosis after coronary stenting in humans. Circulation 105:2974–2980PubMedCrossRefGoogle Scholar
  68. 68.
    Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R (2011) The pathology of neoatherosclerosis in human coronary implants; bare-metal and drug-eluting stents. J Am Coll Cardiol 57:1314–1422PubMedCrossRefGoogle Scholar
  69. 69.
    Habara M, Terashima M, Nasu K, Inoue K, Ito T, Kamikawa S, Kurita T, Tanaka N, Kimura M, Kinoshita Y, Tsuchikane E, Matsuo H, Ueno K, Katoh O, Suzuki T (2011) Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study. Circ Cardiovasc Interv 4:232–238PubMedCrossRefGoogle Scholar
  70. 70.
    Park KW, Kim CH, Lee HY et al (2010) Does “late catch-up” exist in drug-eluting stents: insights form a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents. Am Heart J 159:446–453PubMedCrossRefGoogle Scholar
  71. 71.
    Claessen BE, Beijk MA, Legrand V et al (2009) Two-year clinical angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. Circ Cardiovasc Interv 2:239–247CrossRefGoogle Scholar
  72. 72.
    Farooq V, Gogas BD, Serruys PW (2011) Restenosis; delineating the numerous causes for drug-eluting stent restenosis. Circ Cardiovasc Interv 4:195–205PubMedCrossRefGoogle Scholar
  73. 73.
    Kang S-J, Mintz GS, Park D-W, Lee S-W, Kim Y-H, Lee CW, Han K-H, Kim J-J, Park S-W, Par S-J (2011) Mechanisms of in-stent restenosis after drug-eluting stent implantation; intravascular ultrasound analysis. Circ Cardiovasc Interv 4:9–14PubMedCrossRefGoogle Scholar
  74. 74.
    Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, Costa RA, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps E, Collins MB, Colombo A, Stone GW, Leon MB, Moses JW (2004) Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 110:3430–3434PubMedCrossRefGoogle Scholar
  75. 75.
    Papafaklis MI, Bourantas CV, Theodorakis PE et al (2010) The effect of shear stress on neointimal response following sirolimus- and paclitaxel- eluting stent implantation compared with bare-metal stents in humans. JACC Cardiovasc Interv 3:1181–1183PubMedCrossRefGoogle Scholar
  76. 76.
    Lara-Gomez J, Brugaletta S, Farooq V, van Geus RJ, De Bruyne B, Windecker S, McLean D, Thuessen L, Dudek D, Koolen J, Whitbourn R, Smits PC, Chevalier B, Morel M-A, Dorange C, Veldhof S, Rapoza R, Garcia-Garcia HM, Ormiston JA, Serruys PW (2011) Angiographic geometric changes of the lumen arterial wall after bioabsorbable vascular scaffolds and metallic platform stents at 1-year follow-up. JACC Cardiovasc Interv 4:789–799CrossRefGoogle Scholar
  77. 77.
    Kimura T, Abe K, Shizuta S, Odashiro K, Yoshida Y, Sakai K, Kaitani K, Inoue K, Nagakawa Y, Yokoi H, Iwabuchi M, Hamasaki N, Nosaka H (2002) Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 105:2986–2991PubMedCrossRefGoogle Scholar
  78. 78.
    Kuriyama N, Kobayashi Y, Nakamura T, Mine D, Nishihira K, Shimomura M, Nomura K, Ashikaga K, Matsuyama A, Shibata Y (2011) Late restenosis following sirolimus-eluting stent implantation. JACC Cardiovasc Interv 4:123–128PubMedCrossRefGoogle Scholar
  79. 79.
    Giuagliumi G, Musumeci G, Sirbu V, Bezerra HG, Suzuki N, Fiocca L, Matiashvili A, Lortkipanidze N, Trivisonno A, Valsecchi O, Biondi-Zoccai G, Costa MA, on behalf of the ODESSA Trial Investigators (2010) Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv 3:531–539CrossRefGoogle Scholar
  80. 80.
    Kastrati A, Byrne R (2011) New roads, new ruts. JACC Cardiovasc Interv 4:165–167PubMedCrossRefGoogle Scholar
  81. 81.
    Davies MJ, Thomas AC, Knapman PA, Hangartner JR (1986) Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 73:418–427PubMedCrossRefGoogle Scholar
  82. 82.
    Ito H, Ikeda H, Murohara T, Yasukawa H, Haramaki N, Sakisaka S, Imaizumi T (1996) Clinical implications of the “no reflow” phenomenon; a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 93:223–228PubMedCrossRefGoogle Scholar
  83. 83.
    Topol EJ, Yadav JS (2000) Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101:570–580PubMedCrossRefGoogle Scholar
  84. 84.
    Kirtane AJ, Gibson CM (2006) Distal embolization of thrombus in acute myocardial infarction. Am J Med 119:e1–e2PubMedCrossRefGoogle Scholar
  85. 85.
    De Haeck J, Verouden NJW, Henriques JPS, Koch KT (2009) Current status of distal embolization in percutaneous coronary intervention: mechanical and pharmacological strategies. Future Cardiol 5:385–402PubMedCrossRefGoogle Scholar
  86. 86.
    Stone GW, Webb J, Cox DA (2005) Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction; a randomized controlled trial. JAMA 293:1063–1072PubMedCrossRefGoogle Scholar
  87. 87.
    Okamura A, Ito H, Iwakura K, Kurotobi T, Koyama Y, Date M, Higuchi Y, Inoue K, Fujii K (2008) Clinical implications of distal embolization during coronary interventional procedures in patients with acute myocardial infarction; quantitative study with Doppler guidewire. JACC Interv 1:268–276CrossRefGoogle Scholar
  88. 88.
    Saber RS, Edwards WD, Bailey KR, McGovern TW, Schwartz RS, Holmes DR Jr (1993) Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. J Am Coll Cardiol 22:1283–1288PubMedCrossRefGoogle Scholar
  89. 89.
    Selvanayagam JB, Cheng ASH, Jerosch-Herold M, Rahimi K, Porto I, van Gaal W, Channon KM, Neubauer S, Banning AP (2007) Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention; a quantitative magnetic resonance perfusion study. Circulation 116:1458–1464PubMedCrossRefGoogle Scholar
  90. 90.
    Popma JJ (2002) Initial clinical experience with distal protection using FilterWire in patients undergoing coronary artery and saphenous vein graft intervention. Catheter Cardiovasc Interv 57:125–134PubMedCrossRefGoogle Scholar
  91. 91.
    Jaffe R, Dick A, Strauss BH (2010) Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention; a systematic approach. JACC Cardiovasc Interv 3:695–704PubMedCrossRefGoogle Scholar
  92. 92.
    Kloner RA, Ganote CE, Jennings RB (1974) The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54:1496–1508PubMedCrossRefGoogle Scholar
  93. 93.
    Niccolli G, Burzotta F, Galiuto L, Crea F (2009) Myocardial no-reflow in humans. J Am Coll Cardiol 54:281–292CrossRefGoogle Scholar
  94. 94.
    Galiuto L, Lombardo A, Maseri A, Santoro L, Porto I, Cianflone D, Rebuzzi AG, Crea F (2003) Temporal evolution and functional outcome of no-reflow; sustained and spontaneously reversible patterns following successful coronary recanalisation. Heart 89:731–737PubMedCrossRefGoogle Scholar
  95. 95.
    Dong-bao L, Qi H, Zhi L, Shan W, Wei-ying J (2009) Predictors and short-term prognosis of angiographically detected distal embolization after emergency percutaneous coronary intervention for ST-elevation acute myocardial infarction. Clin Res Cardiol 98:773–779PubMedCrossRefGoogle Scholar
  96. 96.
    Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J, Alger P, Mehilli J, Schömig A, Kastrati A (2010) 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55:2383–2389PubMedCrossRefGoogle Scholar
  97. 97.
    Cura FA, Escudero AG, Berrocal D, Mendiz O, Trivi MS, Fernandez J, Palacios A, Albertal M, Piraino R, Ricitelli MA, Gruberg L, Ballarino M, Millei J, Baeza R, Thierer J, Grinfeld L, Krucoff M,O’Neill WO, Belardi J, Premier Investigators (2007) Protection of distal embolizaton in high-risk patients with acute ST-Segment elevation myocardial infarction (PREMIAR). Am J Cardiol 99:357–363PubMedCrossRefGoogle Scholar
  98. 98.
    Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA, for the FilterWire EX Randomized Evaluation (FIRE) Investigators (2003) Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 108:548–553PubMedCrossRefGoogle Scholar
  99. 99.
    Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Pavliska J, Wahr D, Rogers C (2007) The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol 50:1442–1449PubMedCrossRefGoogle Scholar
  100. 100.
    Goto K, Lansky AJ, Nikolsky E, Fahy M, Feit F, Ohman M, White HD, Mehran R, Bertrand ME, Desmet W, Hamon M, Stone GW (2011) Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes. JACC Cardiovasc Interv 4:769–771PubMedCrossRefGoogle Scholar
  101. 101.
    Cohen MG (2010) Intracoronary thrombus; a sticky problem. JACC Cardiovasc Interv 3:947–949PubMedCrossRefGoogle Scholar
  102. 102.
    McFadden EP, Stabile E, Regar E et al (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364:1519–1521PubMedCrossRefGoogle Scholar
  103. 103.
    Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R (2007) Drug-eluting stent and coronary thrombosis: biological mechanism and clinical implications. Circulation 115:1051–1058PubMedCrossRefGoogle Scholar
  104. 104.
    Cutlip DE, Nakazawa G, Krucoff MW, Vorphahl M, Mehran R, Finn AV, Vranckx P, Kimmelstiel C, Berger C, Petersen JL, Palabrica T, Virmani R (2011) Autopsy validation study of the Academic Research Consortium stent thrombosis definition. JACC Cardiovasc Interv 4:554–559PubMedCrossRefGoogle Scholar
  105. 105.
    Nordmann AJ, Briel M, Bucher C (2006) Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27:2784–2814PubMedCrossRefGoogle Scholar
  106. 106.
    Mauri L, Hsieh WH, Massaro JM, Ho KK, D’Agostino R, Cutlip DE (2007) Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356:1020–1029PubMedCrossRefGoogle Scholar
  107. 107.
    Pfisterer M, Brunner-La Roca HP, Buser PT et al (2006) Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents; an observational study of drug-eluting stents versus bare-metal stents. J Am Coll Cardiol 48:2584–2591PubMedCrossRefGoogle Scholar
  108. 108.
    Daemen J, Wenaweser P, Tsuchida K, Albrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369:667–678PubMedCrossRefGoogle Scholar
  109. 109.
    Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehrah R, Leon MB (2007) Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356:998–1008PubMedCrossRefGoogle Scholar
  110. 110.
    Camenzind E, Steg PG, Wijns W et al (2007) Stent thrombosis later after implantation of first-generation drug-eluting stents; a cause for concern. Circulation 115:1440–1455PubMedCrossRefGoogle Scholar
  111. 111.
    Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, Dangas G (2009) Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol 53:1677–1689PubMedCrossRefGoogle Scholar
  112. 112.
    Brodie B, Pohharel Y, Fleishman N, Bensimhon A, Kissling G, Hansen C, Milks S, Cooper M, McAlhany C, Stuckey T (2011) Very late stent thrombosis after percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-Segment elevation myocardial infarction; a 15-year single-center experience. JACC Cardiovasc Interv 4:30–38PubMedCrossRefGoogle Scholar
  113. 113.
    Aoki J, Lansky AJ, Mehran R, Moses J, Bertrand ME, McLaurin BT, Cox DA, Lincoff AM, Ohman EA, White HD, Parise H, Leon MB, Stone GW (2009) Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents; the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation 119:687–698PubMedCrossRefGoogle Scholar
  114. 114.
    Dangas GD, Caixeta A, Mehran R, Parise H, Lansky AJ, Cristea E, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Möeckel M, Stone GW, for HORIZONS-AMI Trial Investigators (2011) Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation 123:1745–1756PubMedCrossRefGoogle Scholar
  115. 115.
    Palmerini T, Dangas G, Mehran R, Caixeta A, Genereux P, Fahy M, Xu K, Cristea E, Lansky A, Stone GW (2011) Predictors and implications of stent thrombosis in Not-ST-segment elevation acute coronary syndromes: the ACUITY trial. Circ Cardiovasc Interv 4(6):577–584, Epub 2011 Oct 25PubMedCrossRefGoogle Scholar
  116. 116.
    Windecker S, Räber L (2010) The DESIRE-late registry; what is left to be desired? JACC Cardiovasc Interv 3:19–21PubMedCrossRefGoogle Scholar
  117. 117.
    de la Torre Hernandez JM, Alfonso F, Gimeno F, Diarte JA, Lopez-Palop R, de Prado AP, Rivero F, Sanchis J, Larman M, Diaz JF, Elizaga J, Moreiras JM, Jaume AG, Hernandez JM, Mauri J, Recalde AS, Bullones JA, Rumoroso JR, del Blanco BG, Baz JA, Bosa F, Botas J, Hernandez F, on behalf of the ESTROFA-2 study group (2010) Thrombosis of second-generation drug-eluting stents in real practice; results from the Multicenter Registry ESTROFA-2 (Estudio Espanol Sobre Trombosis de Stents Farmaactivos de Segunda Generation-2). JACC Cardiovasc Interv 3:911–919PubMedCrossRefGoogle Scholar
  118. 118.
    Honda Y, Fitzgerald PJ (2003) Stent thrombosis; an issue revisited in a changing world. Circulation 108:2–5PubMedCrossRefGoogle Scholar
  119. 119.
    Montalescot G, Hulot J-S, Collet J-P (2009) Stent thrombosis: who’s guilty? Eur Heart J 30:2685–2688PubMedCrossRefGoogle Scholar
  120. 120.
    Berheanu SC, Pons D, Karalis I, Özsoy O, Verschuren JJW, Ewing MM, Quax PHA, Jukema JW (2011) Potential genetic determinants of adverse outcome after stent implantations; results, limitations and perspectives. Future Med Interv Cardiol 2:147–157CrossRefGoogle Scholar
  121. 121.
    Brott BC (2011) Linking drug-eluting stent kinetics and clinical outcomes. JACC Cardiovasc Interv 4:786–788PubMedCrossRefGoogle Scholar
  122. 122.
    Koandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich K-L, Giddings VL, Coleman L, Wong GK, Edelman ER (2011) Stent thrombogenecity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 123:1400–1409CrossRefGoogle Scholar
  123. 123.
    Farb A, Burke AP, Kolodgie FD, Virmani R (2003) Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108:1701–1706PubMedCrossRefGoogle Scholar
  124. 124.
    Joner M, Fin AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans; delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202PubMedCrossRefGoogle Scholar
  125. 125.
    Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R (2008) Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118:1138–1145PubMedCrossRefGoogle Scholar
  126. 126.
    Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R (2011) Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol 57:390–398PubMedCrossRefGoogle Scholar
  127. 127.
    Guo N, Maehara A, Mintz GS, He Y, Xu K, Wu X, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Stone GW (2010) Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction; an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarctions (HORIZONS-AMI) trial. Circulation 122:1077–1084PubMedCrossRefGoogle Scholar
  128. 128.
    Choi S-Y, Witzenbichler B, Maehara A, Lansky AJ, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Dangas GD, Mintz GS, Stone GW (2011) Intravascular ultrasound findings of early thrombosis after primary percutaneous intervention in acute myocardial infarction; Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarctions (HORIZONS-AMI) substudy. Circ Cardiovasc Interv 4:239–247PubMedCrossRefGoogle Scholar
  129. 129.
    Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ (2010) Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 362:1663–1674PubMedCrossRefGoogle Scholar
  130. 130.
    Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carozza JP Jr, Chauhan MS, Rodriques O, Kuntz RE (2001) Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103:1967–1971PubMedCrossRefGoogle Scholar
  131. 131.
    Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126–2130PubMedCrossRefGoogle Scholar
  132. 132.
    Belle L, Mahmoudi M, Delhaye C, Ben-Dor I, Maluenda G, Gaglia MA Jr, Torguson R, Satler LF, Pichard AD, Waksman R (2011) Do patients with drug-eluting stent thrombosis have a similar prognosis to patients presenting with ST-segment elevation myocardial infarction of de novo lesions? J Interv Cardiol 24:320–325PubMedCrossRefGoogle Scholar
  133. 133.
    Mintz GS (2007) What to do about late incomplete stent apposition? Circulation 115:2379–2381PubMedCrossRefGoogle Scholar
  134. 134.
    Mintz GS, Shah VM, Weissman NJ (2003) Regional remodeling as the cause of late stent malapposition. Circulation 107:2660–2663PubMedCrossRefGoogle Scholar
  135. 135.
    Guo N, Maehara A, Mintz GS, Yong H, Xu K, Wu X, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Stone GW (2010) Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction; an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stent in Acute Myocardial Infarction (HORIZONS-AMI) trial. Circulation 122:1077–1084PubMedCrossRefGoogle Scholar
  136. 136.
    Kang S-J, Mintz GS, Park D-W, Lee S-W, Kim Y-H, Lee CW, Han K-H, Kim J-J, Park S-W, Park S-J (2010) Late and very late drug-eluting stent malapposition; serial 2-year quantitative IVUS analysis. Circ Cardiovasc Interv 3:335–340PubMedCrossRefGoogle Scholar
  137. 137.
    Lindsey JB, Marso SP (2010) Incomplete stent apposition; should we appose or oppose? JACC Cardiovasc Interv 3:495–497PubMedCrossRefGoogle Scholar
  138. 138.
    Cook S, Wenaweser P, Togni M, Billinger M, Moger C, Seiler C, Vogel R, Hess OM, Meier B, Windecker S (2007) Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115:2426–2434PubMedCrossRefGoogle Scholar
  139. 139.
    Lara-Gomez J, Radu M, Brugaletta S, Farooq V, Diletti R, Onuma Y, Windecker S, Thuesen L, McLean D, Koolen J, Whitbourn R, Dudek D, Smits PC, Regar E, Veldhof S, Rapoza R, Ormiston JA, Garcia-Garcia HM, Serruys PW (2011) Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioabsorbable scaffold with optical coherence tomography. JACC Cardiovasc Interv 4:992–1001CrossRefGoogle Scholar
  140. 140.
    Takano M, Yamamoto M, Mizuno M, Murakami D, Inami T, Kimata N, Murai K, Kobayashi N, Okamatsu K, Ohba T, Seino Y, Mizuno K (2010) Late vascular responses from 2 to 4 years after implantation of sirolimus-eluting stents; serial observation by intracoronary optical coherence tomography. Circ Cardiovasc Interv 3:476–483PubMedCrossRefGoogle Scholar
  141. 141.
    Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, Suzuki N, Matiashvili A, Lortkipanidze N, Mihalcsik L, Trivisonno A, Valsecchi O, Mintz GS, Dressler O, Parise H, Maehara A, Cristea E, Lansky AJ, Mehran R, Stone GW (2011) Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction; optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stent in Acute Myocardial Infarction (HORIZONS-AMI) trial. Circulation 123:274–281PubMedCrossRefGoogle Scholar
  142. 142.
    Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R (2009) Incidence and predictors of drug eluting stent fracture in human coronary artery; a pathologic analysis. J Am Coll Cardiol 54:1924–1931PubMedCrossRefGoogle Scholar
  143. 143.
    Lee SH, Park JS, Shin DG et al (2007) Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol 100:627–630PubMedCrossRefGoogle Scholar
  144. 144.
    Umeda H, Kawai T, Misumida N, Ota T, Hayashi K, Iwase M, Izawa H, Sugino S, Shimizu T, Takeichi Y, Ishiki R, Inagaki H, Ozaki Y, Murohara T (2011) Impact of sirolimus-eluting stent fracture on 4-years clinical outcomes. Circ Cardiovasc Interv 4:349–354PubMedCrossRefGoogle Scholar
  145. 145.
    Alfonso F, Perez-Vizcayno M-J, Ruiz M, Suarez A, Cazares M, Hernandez R, Escaned J, Banuelos C, Jimenez-Quevedo P, Macaya C (2009) Coronary aneurysms after drug-eluting stent implantation. J Am Coll Cardiol 53:2053–2060PubMedCrossRefGoogle Scholar
  146. 146.
    Aoki J, Kirtane J, Leon MB, Dangas G (2008) Coronary artery aneurysm after drug-eluting stent implantation. JACC Cardiovasc Interv 1:14–21PubMedCrossRefGoogle Scholar
  147. 147.
    Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701–705PubMedCrossRefGoogle Scholar
  148. 148.
    Samore MH, Wessolossky MA, Lewis SM, Shuhbrooks SJ Jr, Karchmer AW (1997) Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol 79:873–877PubMedCrossRefGoogle Scholar
  149. 149.
    Ramsdale DR, Aziz S, Newall N, Palmer N, Jackson M (2004) Bacteremia following complex percutaneous coronary intervention. J Invasive Cardiol 16:632–634PubMedGoogle Scholar
  150. 150.
    Kaufmann BA, Kaiser C, Pfisterer ME, Bonetti PO (2005) Coronary stent infection: a rare but severe complication of percutaneous coronary stenting. Swiss Med Wkly 135:483–487PubMedGoogle Scholar
  151. 151.
    Joner M, Nakazawa G, Finn AV et al (2008) Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 52:333–342PubMedCrossRefGoogle Scholar
  152. 152.
    Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R (2007) Pathological correlates of the late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435–2441PubMedCrossRefGoogle Scholar
  153. 153.
    Kim JW, Suh SY, Choi CU et al (2008) Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting versus paclitaxel eluting stents. JACC Cardiovasc Interv 1:65–71PubMedCrossRefGoogle Scholar
  154. 154.
    Kim JW, Seo HS, Park JH, Na JO, Choi CU, Lim HE, Kim EJ, Rha S-W, Park CG, Oh DJ (2009) A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus sirolimus- eluting stent. J Am Coll Cardiol 53:1653–1659PubMedCrossRefGoogle Scholar
  155. 155.
    Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, Meier B, Hess OM (2005) Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46:231–236PubMedCrossRefGoogle Scholar
  156. 156.
    Lerman A, Zeiher A (2005) Endothelial function; cardiac events. Circulation 111:363–368PubMedCrossRefGoogle Scholar
  157. 157.
    Fujikura H, Hata Y, Morino Y, Matsuzaki A, Oikawa K, Ikari Y, Taguchi J (2006) Acute coronary syndrome due to intramural hematoma. Circulation 114:e644–e645PubMedCrossRefGoogle Scholar
  158. 158.
    Murphy DA, Craver JM, King SB (1984) Distal coronary dissection following percutaneous transluminal coronary angioplasty. Ann Thorac Surg 37:473–478PubMedCrossRefGoogle Scholar
  159. 159.
    Maehara A, Mintz CS, Bui AB, Castagna MT, Walter OR, Pappas C, Pinnow EE, Pichard AD, Satler LF, Waksman R, Suddath WO, Laird JR Jr, Kent KM, Weisman NJ (2002) Incidence, morphology, angiographic findings, and outcome of intramural hematomas after percutaneous coronary interventions; an intravascular ultrasound study. Circulation 105:2037–2042PubMedCrossRefGoogle Scholar
  160. 160.
    Ellis SG, Ajluni S, Arnold AZ, Popma JJ, Bittl JA, Eigler NL, Cowley MJ, Raymond RE, Safian RD, Whitlow PL (1994) Increased coronary perforation in the new device era. Incidence, classification, management and outcome. Circulation 90:2725–2730PubMedCrossRefGoogle Scholar
  161. 161.
    Shimony A, Zahnger D, van Straten M, Shaley A, Glutz H, Ilia R, Cafri C (2009) Incidence, risk factors, management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 104:1674–1677PubMedCrossRefGoogle Scholar
  162. 162.
    Al-Lamee R, Ielasi A, Latib A, Godino C, Ferraro M, Mussardo M, Arioli F, Carlino M, Montorfano M, Chieffo A, Colombo A (2011) Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation. JACC Cardiovasc Interv 4:87–95PubMedCrossRefGoogle Scholar
  163. 163.
    Capone G, Wolf NM, Meyer B, Meister SG (1985) Frequency of intracoronary filling defects by angiography in angina pectoris at rest. Am J Cardiol 56:403–406PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Department of Internal Medicine, Division of Cardiovascular DiseaseGesundheitszentrum Bitterfeld/Wolfen gGmbHBitterfeld-WolfenGermany

Personalised recommendations